FDA grants CLIA waiver expanding the availability of rapid screening test for syphilis

The U.S. Food and Drug Administration today announced that it granted the first-ever waiver, under certain laboratory regulations, for a rapid screening test for syphilis, which will allow the Syphilis Health Check test to be used in a greater variety of healthcare settings.
Source: Food and Drug Administration - Category: American Health Source Type: news